Single-cell genomics and spatial multiomics will provide more rigorous quantitative assessments of UBR4-mediated senescence and its interplay with the tumor microenvironment, potentially indicating the clinical relevance of UBR4-targeting strategies in treating LUAD and other cancers with dysregulated mitochondrial homeostasis. This evidence concerns the gene UBR4 and neoplasm.